A new trading day began on Monday, with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) stock price up 7.29% from the previous day of trading, before settling in for the closing price of $547.96. MDGL’s price has ranged from $265.00 to $577.90 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -32.06%. Meanwhile, its annual earnings per share averaged 51.30%. With a float of $20.62 million, this company’s outstanding shares have now reached $22.70 million.
Madrigal Pharmaceuticals Inc (MDGL) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Madrigal Pharmaceuticals Inc is 9.19%, while institutional ownership is 104.14%. The most recent insider transaction that took place on Nov 21 ’25, was worth 1,082,986. In this transaction Chief Commercial Officer of this company sold 1,958 shares at a rate of $553.11, taking the stock ownership to the 10,032 shares. Before that another transaction happened on Nov 21 ’25, when Company’s Officer proposed sale 894 for $542.12, making the entire transaction worth $484,655.
Madrigal Pharmaceuticals Inc (MDGL) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Trading Performance Indicators
Here are Madrigal Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.01, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach 3.02 in one year’s time.
Technical Analysis of Madrigal Pharmaceuticals Inc (MDGL)
Looking closely at Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), its last 5-days average volume was 0.44 million, which is a jump from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 72.86%.
During the past 100 days, Madrigal Pharmaceuticals Inc’s (MDGL) raw stochastic average was set at 97.73%, which indicates a significant increase from 95.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.43 in the past 14 days, which was higher than the 18.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $460.21, while its 200-day Moving Average is $361.67. However, in the short run, Madrigal Pharmaceuticals Inc’s stock first resistance to watch stands at $606.94. Second resistance stands at $625.96. The third major resistance level sits at $656.93. If the price goes on to break the first support level at $556.95, it is likely to go to the next support level at $525.98. Now, if the price goes above the second support level, the third support stands at $506.96.
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Key Stats
With a market capitalization of 13.35 billion, the company has a total of 22,711K Shares Outstanding. Currently, annual sales are 180,130 K while annual income is -465,890 K. The company’s previous quarter sales were 287,270 K while its latest quarter income was -114,190 K.
